Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder
Status:
Unknown status
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This study evaluates the use of Rhodiola rosea in the attention of adults with Attention
Deficit/Hyperactivity Disorder (ADHD). Half of participants will receive Rhodiola rosea
800mg, while the other half will receive 800mg of placebo.